Showing results (281-290 of 315) with videos related to
Sort By:
Pageof 32
Cancer Research|July 15, 1995
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosisG A Piazza, A L Rahm, M Krutzsch, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratoriesD J Roe, D S Alberts, M J Wargovich, et al.Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.British Journal of Cancer|November 1, 1996
Expression of the zinc finger gene EVI-1 in ovarian and other cancersD J Brooks, S Woodward, F H Thompson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixW A Peters, P Y Liu, R J Barrett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancerD S Alberts, S Green, E V Hannigan, et al.Nutrition and Cancer|January 1, 1996
Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmeticsD S Alberts, R Goldman, M J Xu, et al.Cancer|January 15, 1993
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group studyD S Alberts, S Dahlberg, S J Green, et al.Journal of the National Cancer Institute|December 2, 1992
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancerC W Taylor, D S Alberts, Y M Peng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drugD S Alberts, A V Hallum, M Stratton-Custis, et al.Pageof 32